{
    "Trade/Device Name(s)": [
        "microINR System",
        "microINR Meter",
        "microINR Chip"
    ],
    "Submitter Information": "iLine Microsystems, S.L.",
    "510(k) Number": "K201185",
    "Predicate Device Reference 510(k) Number(s)": [
        "K180780"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "GJS"
    ],
    "Summary Letter Date": "December 18, 2020",
    "Summary Letter Received Date": "May 1, 2020",
    "Submission Date": "April 27, 2020",
    "Regulation Number(s)": [
        "21 CFR 864.7750"
    ],
    "Regulation Name(s)": [
        "Prothrombin Time Test"
    ],
    "Analyte Class(es)": [
        "coagulation"
    ],
    "Analyte(s)": [
        "Prothrombin time (PT)",
        "International Normalized Ratio (INR)"
    ],
    "Specimen Type(s)": [
        "Capillary whole blood"
    ],
    "Specimen Container(s)": [
        "Fingerstick"
    ],
    "Instrument(s)/Platform(s)": [
        "microINR Meter"
    ],
    "Method(s)/Technology(ies)": [
        "Microfluidic technology",
        "Machine vision detection",
        "Dry chemistry reagent"
    ],
    "Methodologies": [
        "Clotting time assay"
    ],
    "Submission Type(s)": [
        "System",
        "Instrument",
        "Reagent",
        "Chip",
        "Analyzer"
    ],
    "Document Summary": "FDA 510(k) summary for the microINR System, a handheld device using microfluidic and machine vision technologies to measure prothrombin time (INR) for oral anticoagulant therapy monitoring.",
    "Indications for Use Summary": "Measures prothrombin time (INR) using capillary whole blood from a fingerstick for monitoring oral anticoagulant (warfarin) therapy; intended for self-testing by trained patients and use by healthcare professionals in point-of-care settings; not for screening or use in patients transitioning from heparin to warfarin.",
    "fda_folder": "Hematology"
}